DR.NUELL MUGWORT SHAKING PACK- glycerin liquid 
Apharm Co., Ltd.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

glycerin

dual functionality for brightening and wrinkle improvement certified

Keep out of reach of children

1. put 1st and 2nd packs in the pouch and seal them and shake them for 10 seconds

2. sweep the contents down and tear them along the bottom cut line

3. apply mixture to the fact with a sqag-hola and gently remove it from the bottom to the top after 20~30 minutes

4. remove the pack and apply skin product

1) if there is any abnormal symptom or side effect, such as red spot, swelling and itching when using cosmetlcs or after using due to direct sunlight, consult dermatologists
2) Do not use for wounded areas
3) Precautions for storage and handling
keep out of reach of children, store away from direct sunlight
4) avoid the eye area

water, butylene glycol, 1,2-hexanediol, citric acid, etc

For external use only

label

DR.NUELL MUGWORT SHAKING PACK 
glycerin liquid
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73430-0002
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN5.021 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
ALLANTOIN (UNII: 344S277G0Z)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:73430-0002-170 g in 1 PACKAGE; Type 0: Not a Combination Product11/01/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart34711/01/2019
Labeler - Apharm Co., Ltd. (689054266)
Registrant - Apharm Co., Ltd. (689054266)
Establishment
NameAddressID/FEIBusiness Operations
APHARM Co., Ltd.689054266manufacture(73430-0002)

Revised: 11/2019
Document Id: 966975e5-cd16-26bd-e053-2a95a90a7356
Set id: 9669740b-c5ba-27e1-e053-2a95a90a7c31
Version: 1
Effective Time: 20191102
 
Apharm Co., Ltd.